Amiodarone Should Be the First-Line Antiarrhythmic Treatment for Pulseless Ventricular Tachycardia and Ventricular Fibrillation. Rech MA, Gottlieb M. Ann Emerg Med 2025;85:447-448.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rech MA, Gottlieb M. Amiodarone Should Be the First-Line Antiarrhythmic Treatment for Pulseless Ventricular Tachycardia and Ventricular Fibrillation. Ann Emerg Med 2025;85:447-448.
PMID: 40254377